Cover Image
Market Research Report

Transcatheter Mitral Valve Implantation (TMVI) - Medical Devices Pipeline Assessment, 2019

Published by GlobalData Product code 758982
Published Content info 114 Pages
Delivery time: 1-2 business days
Price
Back to Top
Transcatheter Mitral Valve Implantation (TMVI) - Medical Devices Pipeline Assessment, 2019
Published: December 18, 2019 Content info: 114 Pages
Description

GlobalData's Medical Devices sector report, "Transcatheter Mitral Valve Implantation (TMVI) - Medical Devices Pipeline Assessment, 2019" provides an overview of Transcatheter Mitral Valve Implantation (TMVI) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transcatheter Mitral Valve Implantation (TMVI) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transcatheter Mitral Valve Implantation (TMVI) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Mitral Valve Implantation (TMVI) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Mitral Valve Implantation (TMVI) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME0877EPD

Table of Contents

  • 1.1 List of Tables 4
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 Transcatheter Mitral Valve Implantation (TMVI) Overview 8

3 Products under Development 9

  • 3.1 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development 9
  • 3.2 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory 10
  • 3.3 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path 11
  • 3.4 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date 12
  • 3.5 Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials 13

4 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products under Development by Companies 14

  • 4.1 Transcatheter Mitral Valve Implantation (TMVI) Companies - Pipeline Products by Stage of Development 14
  • 4.2 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development 15

5 Transcatheter Mitral Valve Implantation (TMVI) Companies and Product Overview 17

  • 5.1 4C Medical Technologies Inc Company Overview 17
    • 5.1.1 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.2 Annulon Company Overview 20
    • 5.2.1 Annulon Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.3 CardioMech AS Company Overview 21
    • 5.3.1 CardioMech AS Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.4 Cardiovalve Ltd Company Overview 22
    • 5.4.1 Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.5 Cephea Valve Technologies, Inc. Company Overview 26
    • 5.5.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.6 Colibri Heart Valve LLC Company Overview 29
    • 5.6.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.7 Daidalos Solutions BV Company Overview 30
    • 5.7.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.8 Direct Flow Medical Inc (Inactive) Company Overview 31
    • 5.8.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.9 Dura LLC Company Overview 32
    • 5.9.1 Dura LLC Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.10 Edwards Lifesciences Corp Company Overview 33
    • 5.10.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.11 Emory University Company Overview 46
    • 5.11.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.12 Foldax Inc Company Overview 47
    • 5.12.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.13 HighLife SAS Company Overview 48
    • 5.13.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.14 LivaNova PLC Company Overview 51
    • 5.14.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.15 Medtronic plc Company Overview 55
    • 5.15.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.16 Micro Interventional Devices, Inc. Company Overview 60
    • 5.16.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.17 MitrAssist Ltd. Company Overview 61
    • 5.17.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.18 MValve Technologies Ltd. Company Overview 62
    • 5.18.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.19 NaviGate Cardiac Structures, Inc. Company Overview 65
    • 5.19.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.20 Neovasc Inc Company Overview 68
    • 5.20.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.21 Polares Medical SA Company Overview 72
    • 5.21.1 Polares Medical SA Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.22 Sino Medical Sciences Technology Inc Company Overview 73
    • 5.22.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.23 Trinity College Dublin Company Overview 74
    • 5.23.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.24 University College London Company Overview 75
    • 5.24.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.25 Venus MedTech Company Overview 76
    • 5.25.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview 76

6 Transcatheter Mitral Valve Implantation (TMVI)- Recent Developments 77

  • 6.1 Nov 21, 2019: LivaNova to revamp heart valve division to affect 150 jobs 77
  • 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 77
  • 6.3 Oct 23, 2019: Edwards Lifesciences reports third quarter results 80
  • 6.4 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 83
  • 6.5 Oct 15, 2019: Neovasc announces Notice of US Patent Granted for TiaraTranscatheter Device for treatment of severe mitral regurgitation 84
  • 6.6 Oct 10, 2019: CINDE announces Edwards Lifesciences invests $100 million to expand its operations in Costa Rica 84
  • 6.7 Sep 30, 2019: AltaValve, 4C Medical's Novel Transcatheter Mitral Regurgitation Device Highlighted at TCT 2019 86
  • 6.8 Sep 27, 2019: Medtronic announces early feasibility Trial for Intrepid Transcatheter Mitral Valve Replacement System with Transfemoral Transseptal approach 86
  • 6.9 Aug 28, 2019: Medtronic announces planned leadership succession 87
  • 6.10 Aug 20, 2019: Medtronic reports first quarter financial results for 2019 89
  • 6.11 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 91
  • 6.12 Jul 23, 2019: Edwards Lifesciences reports second quarter results for the year 2019 92
  • 6.13 Jun 17, 2019: Tiara featured in presentation at 11th Annual TVT 2019 English 94
  • 6.14 May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results 94
  • 6.15 May 22, 2019: Edwards announces milestones for Transcatheter Mitral Program 97
  • 6.16 May 20, 2019: Novel technique reduces obstruction risk in heart valve replacement 98
  • 6.17 Apr 23, 2019: Edwards Lifesciences announces first quarter results 99
  • 6.18 Apr 17, 2019: Neovasc announces resolution of last remaining active litigation 100
  • 6.19 Mar 25, 2019: Medtronic launches Medtech Innovation Accelerator in Shanghai 101
  • 6.20 Mar 21, 2019: Neovasc wins German court appeal; announces german court's Decision to dismiss CardiAQ's claim to co-inventorship of a European patent for Tiara 102
  • 6.21 Mar 04, 2019: Neovasc's Tiara Mitral Valve replacement technology featured in update presentation at the CRT 2019 Meeting 103
  • 6.22 Feb 25, 2019: 4C Medical's novel mitral regurgitation therapy to be highlighted at CRT 2019 Meeting 104
  • 6.23 Feb 21, 2019: Edwards Lifesciences secures CE-Mark for Pascal system 104
  • 6.24 Feb 21, 2019: Neovasc celebrates 5-year anniversary of Tiara patient as the longest surviving transcatheter mitral valve replacement in the world 105
  • 6.25 Feb 20, 2019: Micro Interventional Devices reaches settlement agreement with Neovasc 106
  • 6.26 Jan 31, 2019: Edwards Lifesciences reports financial results for the quarter ended December 31, 2018 106
  • 6.27 Jan 29, 2019: Neovasc receives approval to proceed with phase 2 of TIARA-II study from clinical regulators in Germany and the UK 108
  • 6.28 Jan 22, 2019: Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences 109
  • 6.29 Jan 15, 2019: Boston Scientific, Edwards Lifesciences agree to global litigation settlement 109
  • 6.30 Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare 109

7 Appendix 111

  • 7.1 Methodology 111
  • 7.2 About GlobalData 114
  • 7.3 Contact Us 114
  • 7.4 Disclaimer 114

List of Tables

  • Table 1: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
  • Table 2: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory
  • Table 3: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path
  • Table 4: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date
  • Table 5: Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials
  • Table 6: Transcatheter Mitral Valve Implantation (TMVI) Companies - Pipeline Products by Stage of Development
  • Table 7: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
  • Table 8: 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: AltaValve - Product Status
  • Table 10: AltaValve - Product Description
  • Table 11: 4C Medical Technologies Inc - Ongoing Clinical Trials Overview
  • Table 12: AltaValve - AltaValve Early Feasibility Study Protocol
  • Table 13: Annulon Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Mitral Valve Replacement Device - Product Status
  • Table 15: Mitral Valve Replacement Device - Product Description
  • Table 16: CardioMech AS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Transcatheter Mitral Valve Repair System - Product Status
  • Table 18: Transcatheter Mitral Valve Repair System - Product Description
  • Table 19: Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Valtech Cardiovalve - Product Status
  • Table 21: Valtech Cardiovalve - Product Description
  • Table 22: Cardiovalve Ltd - Ongoing Clinical Trials Overview
  • Table 23: Valtech Cardiovalve - Cardiovalve Transfemoral Mitral Valve System in Patients at High Surgical Risk with Severe Mitral Regurgitation
  • Table 24: Valtech Cardiovalve - Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
  • Table 25: Valtech Cardiovalve - Early Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
  • Table 26: Valtech Cardiovalve - European Feasibility Study of High Surgical Risk Patients with Severe Mitral Regurgitation Treated with the Cardiovalve Transfemoral Mitral Valve System (AHEAD Study)
  • Table 27: Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Mitral Valve Replacement Device - Product Status
  • Table 29: Mitral Valve Replacement Device - Product Description
  • Table 30: Cephea Valve Technologies, Inc. - Ongoing Clinical Trials Overview
  • Table 31: Mitral Valve Replacement Device - Cephea Mitral Valve and Transseptal Delivery System FIH
  • Table 32: Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Mitral Valve - Product Status
  • Table 34: Mitral Valve - Product Description
  • Table 35: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Status
  • Table 37: Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Description
  • Table 38: Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Direct Flow Medical Transcatheter Mitral Valve - Product Status
  • Table 40: Direct Flow Medical Transcatheter Mitral Valve - Product Description
  • Table 41: Dura LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Sutra TMVR System - Product Status
  • Table 43: Sutra TMVR System - Product Description
  • Table 44: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: CardiAQ Mitral Valve - Product Status
  • Table 46: CardiAQ Mitral Valve - Product Description
  • Table 47: EVOQUE Mitral Valve Replacement Device - Product Status
  • Table 48: EVOQUE Mitral Valve Replacement Device - Product Description
  • Table 49: FORTIS Mitral Transcatheter Heart Valve - Product Status
  • Table 50: FORTIS Mitral Transcatheter Heart Valve - Product Description
  • Table 51: PASCAL Transcatheter Mitral Valve Repair System - Product Status
  • Table 52: PASCAL Transcatheter Mitral Valve Repair System - Product Description
  • Table 53: Sapien 3 Heart Valve - Mitral Annular Calcification - Product Status
  • Table 54: Sapien 3 Heart Valve - Mitral Annular Calcification - Product Description
  • Table 55: SAPIEN M3 - Product Status
  • Table 56: SAPIEN M3 - Product Description
  • Table 57: Second Generation Transapical Transcatheter Mitral Valve - Product Status
  • Table 58: Second Generation Transapical Transcatheter Mitral Valve - Product Description
  • Table 59: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
  • Table 60: FORTIS Mitral Transcatheter Heart Valve - Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation
  • Table 61: CardiAQ Mitral Valve - Early Feasibility Study of the Edwards EVOQUE Transcatheter Mitral Valve Replacement System For the Treatment of Moderate to Severe Mitral Regurgitation
  • Table 62: Sapien 3 Heart Valve - Mitral Annular Calcification - Surgical Implantation of Transcatheter valve in Native Mitral Annular Calcification (SITRAL) Study
  • Table 63: Sapien 3 Heart Valve - Mitral Annular Calcification - The Safety and Feasibility of the SAPIEN XT Transcatheter Heart Valve with Novaflex and Ascendra Delivery Systems and SAPIEN 3 with Commander Delivery System in Patients with Symptomatic Severe Calcific Mitral Valve Disease with Severe Mitral Annular Calcification and Patients with Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery
  • Table 64: PASCAL Transcatheter Mitral Valve Repair System - CE Mark Study of PASCAL Transcatheter Mitral Valve Repair System

List of Figures

  • Figure 1: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
  • Figure 2: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory
  • Figure 3: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path
  • Figure 4: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date
  • Figure 5: Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials
Back to Top